ASCEND GMBH — Everolimus Importer Profile
Pharmaceutical Importer · #1 buyer for Everolimus · $489.1K import value · 27 shipments · GERMANY · DGFT Verified
ASCEND GMBH is the #1 importer of Everolimus from India with $489.1K in import value and 27 verified shipments. ASCEND GMBH holds a 3.6% market share in Everolimus imports based in GERMANY. The company sources from 1 verified supplier across 23 formulations shipped to 1 country. Overall, ASCEND GMBH imports 2 pharmaceutical products worth $3.8M across 1 therapeutic categories.
ASCEND GMBH — Everolimus Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Everolimus to ASCEND GMBH?
Verified from 27 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| ALKEM LABORATORIES LIMITED | $489.1K | 27 | 100.0% |
ASCEND GMBH sources Everolimus from 1 verified Indian supplier based on 27 customs records. The primary supplier is ALKEM LABORATORIES LIMITED accounting for 100.0% of imports.
How Does ASCEND GMBH Compare to Nearest Everolimus Importers?
Buyers ranked immediately above and below #1 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | PHARMACARE PREMIUM | MALTA | $2.3M | 45 | $50.0K |
| 2 | ASCEND LABORATORIES LLC | UNITED STATES | $1.9M | 37 | $50.0K |
| 1 | ASCEND GMBH ★ | GERMANY | $1.4M | 27 | $50.0K |
| 5 | ASCEND LABORATORIES,LLC | UNITED STATES | $1.4M | 27 | $50.0K |
| 8 | BRECKENRIDGE PHARMACEUTICAL, INC | UNITED STATES | $1.1M | 21 | $50.0K |
ASCEND GMBH ranks #1 among 135 Everolimus importers from India. Average shipment value of $50.0K compared to the market average of $105.8K. The closest competitors by value are PHARMACARE PREMIUM and ASCEND LABORATORIES LLC.
Where Does ASCEND GMBH Import Everolimus To?
Destination countries from 27 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| GERMANY | $489.1K | 27 | 100.0% |
ASCEND GMBH imports Everolimus to 1 country. The primary destination is GERMANY receiving 100.0% of shipments worth $489.1K.
What Everolimus Formulations Does ASCEND GMBH Import?
| Formulation | Value | Shipments |
|---|---|---|
| EVEROLIMUS ASCEND 1MG TABLETS EACH UNCOATED TABLET CONTAINS: EVEROLIMUS 1MG [2248 X 10X10'S] BATCH NO. 23121127, 23121 | $50.0K | 1 |
| EVEROLIMUS ASCEND 1MG TABLETS (EACH UNCOATED TABLET CONTAINS: EVEROLIMUS 1MG) [1275 X 10X10'S] BATCH NO. 23123467 MFG DT | $50.0K | 1 |
| EVEROLIMUS ASCEND 1MG TABLETS (EACH UNCOATED TABS CONT. EVEROLIMUS 1MG) [1367 X10X10'S] BATCH NO. 23124018 MFG DT. 12/2 | $50.0K | 1 |
| EVEROLIMUS ASCEND 1MG TABLETS (EACH UNCOATED TABS CONT. EVEROLIMUS 1MG) [1276 X10X10'S] BATCH NO. 24120149 MFG DT. 01/2 | $50.0K | 1 |
| EVEROLIMUS ASCEND 0.75MG TABLETS (EACH UNCOATED TABS CONT. EVEROLIMUS 0.75MG) [1283 X 10X10'S] BATCH NO. 23124017 MFG DT | $40.5K | 1 |
| PHARMACEUTICAL PRODUCTS EVEROLIMUS ASCEND 0,75MG TAB 100 BLIS DE PZN NO18425711 EACH UNCOATED TABLET CONTAINS EVEROL | $39.2K | 1 |
| EVEROLIMUS ASCEND 0.5MG TABLETS (EACH UNCOATED TABS CONT. EVEROLIMUS 0.5MG) [1803 X 10X10'S] BATCH NO. 24120052 MFG DT. | $38.0K | 1 |
| EVEROLIMUS ASCEND 0.5MG TABLETS EACH UNCOATED TABLET CONTAINS: EVEROLIMUS 0.5MG [1450 X 10X10'S] BATCH NO. 23121155 MF | $27.3K | 1 |
| EVEROLIMUS ASCEND 025MG TAB 100 BLISDE PZN NO18425651 EACH UNCOATED TABLET CONTAINS EVEROLIMUS 0.25MG | $25.5K | 1 |
| EVEROLIMUS ASCEND 0.75MG TABLETS EACH UNCOATED TABLET CONTAINS: EVEROLIMUS 0.75MG [830 X 10X10'S] BATCH NO. 23121093 M | $23.5K | 1 |
ASCEND GMBH imports 23 distinct Everolimus formulations from India. The top formulation is EVEROLIMUS ASCEND 1MG TABLETS EACH UNCOATED TABLET CONTAINS: with 1 shipments worth $50.0K.
Regulatory Requirements: Importing Everolimus into Germany
What ASCEND GMBH and other importers must comply with to import Everolimus from India
Regulatory Authority
Federal Institute for Drugs and Medical Devices (BfArM) / European Medicines Agency (EMA) (BfArM/EMA)
Approval Process for Generic Everolimus
Marketing Authorisation Application (MAA) under EU Directive 2001/83/EC. Decentralized or Mutual Recognition Procedure for generics. Requires CTD Module 1–5 dossier.
Typical timeline: 12–18 months via Decentralized Procedure
GMP Requirements
EU GMP (EudraLex Vol. 4) compliance; GMP certificate issued by competent authority; WHO Prequalification accepted as supporting evidence
Import Licence & Documentation
Wholesale Distribution Authorisation (WDA) and Manufacturing/Import Authorisation (MIA) required for importer. Qualified Person (QP) must certify each batch.
Labeling & Packaging
EU labeling per Directive 2001/83/EC; German language patient leaflet (PIL) mandatory; serialization under EU Falsified Medicines Directive (FMD)
Note: EU FMD serialization and tamper-evident packaging mandatory since February 2019. Indian API/FDF manufacturers must hold EU GMP certificate.
Regulatory information is provided for general reference based on publicly available BfArM/EMA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with BfArM/EMA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Everolimus from India and How Much Does ASCEND GMBH Import?
India exported $14.3M worth of Everolimus through 620 shipments from 87 suppliers to 67 countries, serving 135 buyers globally. ASCEND GMBH imports $489.1K of this total, accounting for 3.6% of India's Everolimus exports with 27 shipments from GERMANY. This is verified from 27 customs shipment records covering 23 distinct formulations.
What Is the Average Order Value for ASCEND GMBH's Everolimus Imports?
ASCEND GMBH's average Everolimus order value is $18.1K per consignment, based on 27 shipments totaling $489.1K. ASCEND GMBH is based in GERMANY and ranks #1 among all Everolimus importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Everolimus to ASCEND GMBH?
ASCEND GMBH sources Everolimus from 1 verified Indian supplier: ALKEM LABORATORIES LIMITED ($489.1K, 100.0%). This is based on 27 customs records.
How Does ASCEND GMBH Compare to Other Everolimus Importers?
ASCEND GMBH ranks #1 among 135 Everolimus importers from India with a 3.6% market share. The top 3 importers are BRECKENRIDGE PHARMACEUTICAL INC ($3.1M), PHARMACARE PREMIUM ($2.3M), ASCEND LABORATORIES LLC ($1.9M). ASCEND GMBH processed 27 shipments from GERMANY.
What Other Immunosuppressants Products Does ASCEND GMBH Import?
ASCEND GMBH also imports these immunosuppressants products. Each links to the detailed product page.
About ASCEND GMBH
ASCEND GMBH imports 2 products worth $3.8M. Beyond Everolimus, top products include Mycophenolate. View the complete ASCEND GMBH profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Everolimus — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Everolimus shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: ASCEND GMBH matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as ASCEND GMBH's capped import value divided by total capped export value for Everolimus across all Indian exporters.
- 5.Verified Records: This page is backed by 27 individual customs records matching ASCEND GMBH importing Everolimus, covering 23 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 67+ countries, 135+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Everolimus Import Data for ASCEND GMBH
Access order-level details, pricing data, supplier connections, and competitive analysis for ASCEND GMBH's Everolimus imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
ASCEND GMBH
Full Company Profile →
2 products · $3.8M total trade · 1 categories
ASCEND GMBH × Everolimus
Verified from customs records
Company Overview
Top Products by ASCEND GMBH
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for ASCEND GMBH.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Everolimus. For current order-level data, contact TransData Nexus.